Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06266312

Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer

Led by Maastricht University Medical Center · Updated on 2025-02-20

11

Participants Needed

1

Research Sites

74 weeks

Total Duration

On this page

Sponsors

M

Maastricht University Medical Center

Lead Sponsor

N

Nationaal Fonds tegen Kanker

Collaborating Sponsor

AI-Summary

What this Trial Is About

The primary objective of this study is to investigate the feasibility of a multimodal prehabilitation programme consisting of MIET during neoadjuvant intravenous chemotherapy infusion, HITT and strength training during the last six weeks prior to surgery, and optimising nutritional intake throughout the total preoperative period in patients with breast cancer with respect to recruitment, adherence, dropout, safety and acceptance. The secondary objective is to provide a preliminary evaluation of participant responses to a preoperative multimodal lifestyle intervention, on cardiorespiratory fitness, muscle strength, nutritional status, and fatigue in patients with breast cancer receiving neoadjuvant chemotherapy.

CONDITIONS

Official Title

Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with stage I-III breast cancer eligible for neoadjuvant intravenous chemotherapy at the MUMC+
  • Aged 18 years or older
  • Eastern Cooperative Oncology Group (ECOG) Performance Status Scale grade 0-1
  • Sufficient understanding of the Dutch language
Not Eligible

You will not qualify if you...

  • Tumor that is Human Epidermal growth factor Receptor 2 (HER2) positive
  • Use of scalp cooling during chemotherapy
  • Conditions that severely limit the ability to perform physical exercise
  • Patients considered incapacitated by their attending medical specialist

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Maastricht University Medical Center

Maastricht, Limburg, Netherlands, 6229HX

Actively Recruiting

Loading map...

Research Team

H

Hanneke van Dijk - Huisman, PhD

CONTACT

A

Anouk Weemaes, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here